We serve Chemical Name:(R)-1-(3-Methoxyphenyl)ethanamine CAS:88196-70-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(R)-1-(3-Methoxyphenyl)ethanamine
CAS.NO:88196-70-7
Synonyms:(1R)-1-(3-Methoxyphenyl)ethanamine;(R)-m-Methoxy-α-methylbenzylamine;MFCD00671655;(S)-1-(3′-methoxyphenyl)ethylamine;(R)-1-(3-Methoxyphenyl)ethylamine;(S)-1-(m-methoxyphenyl)ethylamine;Benzenemethanamine, 3-methoxy-α-methyl-, (αR)-;(1R)-1-(3-Methoxyphenyl)ethan-1-amine;1-(R)-(3-methoxyphenol)ethylamine;(S)-1-methyl-m-methoxy-benzyl amine;(S)-m-methoxy-1-phenylethylamine;ZY1&R CO1 &&R Form;(R)-1-(3-Methoxyphenyl)ethanamine;(αR)-3-Methoxy-α-methylbenzenemethanamine;R-3-methoxy-Alpha-methylbenzylamine;(S)-(-)-1-(3-methoxylphenyl)ethylamine
Molecular Formula:C9H13NO
Molecular Weight:151.206
HS Code:2922299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:234.6±23.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.523
PSA:35.25000
Exact Mass:151.099716
LogP:1.35
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2735
Packing Group:III
Contact us for information like (1R)-1-(3-Methoxyphenyl)ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-(-)-1-(3-methoxylphenyl)ethylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenemethanamine, 3-methoxy-α-methyl-, (αR)- Use and application,(S)-m-methoxy-1-phenylethylamine technical grade,usp/ep/jp grade.
Related News: About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. methyl 4-[[[4-(5-methyl-3-phenylisoxazol-4-yl)phenyl]sulfonyl]amino]-4-oxobutanoate manufacturers The ability of a CDMO to lay down good quality audits, knowledge of equipment, packaging configurations, and good capability building of resources, helps in determining a competent CDMO partner. bis(3-ethyl-2-methyl-4,5,6,7-tetrahydroindol-4-ylidene)hydrazine suppliers The most frequently reported adverse events for anifrolumab in the TULIP-1 and TULIP-2 trials were upper respiratory tract infection, bronchitis, infusion-related reactions and herpes zoster. 6-methoxy-quinoline-4-carboxylic acid hydrazide vendor & factory.
